stocks logo

BCLI Valuation

Brainstorm Cell Therapeutics Inc
$
0.000
-1.17(-100.000%)1D
  • Overview
  • Forecast
  • Valuation
  • Earnings

BCLI Relative Valuation

BCLI's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, BCLI is overvalued; if below, it's undervalued.

Historical Valuation

Brainstorm Cell Therapeutics Inc (BCLI) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -4.27. The fair price of Brainstorm Cell Therapeutics Inc (BCLI) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price:0.67
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
-1.27
P/B
Median3y
-0.58
Median5y
3.51
-64.89
FCF Yield
Median3y
-75.98
Median5y
-53.23

Competitors Valuation Multiple

The average P/S ratio for BCLI's competitors is 18.79, providing a benchmark for relative valuation. Brainstorm Cell Therapeutics Inc Corp (BCLI) exhibits a P/S ratio of , which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

FAQ

arrow icon

Is Brainstorm Cell Therapeutics Inc (BCLI) currently overvalued or undervalued?

Brainstorm Cell Therapeutics Inc (BCLI) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -4.27. The fair price of Brainstorm Cell Therapeutics Inc (BCLI) is between NaN to NaN according to relative valuation methord.
arrow icon

What is Brainstorm Cell Therapeutics Inc (BCLI) fair value?

arrow icon

How does BCLI's valuation metrics compare to the industry average?

arrow icon

What is the current P/B ratio for Brainstorm Cell Therapeutics Inc (BCLI) as of Jul 26 2025?

arrow icon

What is the current FCF Yield for Brainstorm Cell Therapeutics Inc (BCLI) as of Jul 26 2025?

arrow icon

What is the current Forward P/E ratio for Brainstorm Cell Therapeutics Inc (BCLI) as of Jul 26 2025?

arrow icon

What is the current Forward P/S ratio for Brainstorm Cell Therapeutics Inc (BCLI) as of Jul 26 2025?